首页 > 最新文献

Open Forum Infectious Diseases最新文献

英文 中文
Burden of Herpes Zoster in Individuals with Chronic Conditions in the Republic of Korea: A Nationwide Population-Based Database Study 大韩民国慢性病患者的带状疱疹负担:基于全国人口的数据库研究
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-18 DOI: 10.1093/ofid/ofae535
Jing Chen, Ju-Young Shin, Sungho Bea, Byong Duk Ye, Dong-Gun Lee, Hyungwoo Kim, Won Suk Choi, Sumitra Shantakumar
Background Chronic conditions (CC) may increase the risk of herpes zoster (HZ) infection, leading to a greater healthcare burden in these individuals compared to those without CCs. It is therefore clinically important to quantify HZ disease burden in individuals with and without CCs, given the rapidly ageing population in the Republic of Korea (ROK). Methods This retrospective cohort study examines the trends in incidence rates (IRs) and incidence rate ratios (IRRs) in individuals with CCs aged ≥18 years using the National Health Insurance Service National Sample Cohort (NHIS-NSC) database from 2010–2019. These patients were stratified by age groups, sex, HZ complications, and CCs. The annual average number of HZ patients, IRs and IRRs were calculated for individuals with and without CCs. Results In total, 729,347 patients with HZ were eligible for the study. HZ IRs were highest in patients with diabetes, followed by chronic obstructive pulmonary disease, chronic kidney disease, asthma, and chronic liver disease, with HZ IRRs following a similar trend. Overall, HZ IRs generally increased with age, typically peaking at 60–64 or 65–69 years and were similar for females and males. HZ IRs were highest among patients without complications, followed by HZ with other, cutaneous, ocular, and neurologic complications across all CCs. For each of the CCs, HZ IRs were consistently higher than that of the non-CC population regardless of sex. Conclusions The findings of this study reiterate the importance of HZ prevention for healthy ageing, especially for CCs populations at increased risk of HZ in the ROK.
背景 慢性疾病(CC)可能会增加带状疱疹(HZ)感染的风险,从而导致这些人的医疗负担比没有 CC 的人更重。因此,鉴于大韩民国(ROK)人口的快速老龄化,量化患有和未患有慢性疾病的人群的 HZ 疾病负担具有重要的临床意义。方法 该回顾性队列研究利用 2010-2019 年国民健康保险服务全国抽样队列(NHIS-NSC)数据库,研究了年龄≥18 岁的 CCs 患者的发病率(IRs)和发病率比(IRRs)的变化趋势。这些患者按年龄组、性别、HZ并发症和CC进行了分层。计算了有CC和没有CC的HZ患者年平均人数、IR和IRR。结果 共有 729 347 名 HZ 患者符合研究条件。糖尿病患者的 HZ IR 最高,其次是慢性阻塞性肺病、慢性肾病、哮喘和慢性肝病,HZ IRR 也呈类似趋势。总体而言,HZ IRs 一般随年龄增长而增加,通常在 60-64 岁或 65-69 岁达到峰值,女性和男性的情况相似。在所有CC中,无并发症患者的HZ IR最高,其次是伴有其他、皮肤、眼部和神经系统并发症的HZ。在每种 CC 中,无论性别如何,HZ IRs 始终高于非 CC 患者。结论 本研究结果重申了预防 HZ 对健康老龄化的重要性,尤其是对韩国 HZ 风险较高的 CCs 人口而言。
{"title":"Burden of Herpes Zoster in Individuals with Chronic Conditions in the Republic of Korea: A Nationwide Population-Based Database Study","authors":"Jing Chen, Ju-Young Shin, Sungho Bea, Byong Duk Ye, Dong-Gun Lee, Hyungwoo Kim, Won Suk Choi, Sumitra Shantakumar","doi":"10.1093/ofid/ofae535","DOIUrl":"https://doi.org/10.1093/ofid/ofae535","url":null,"abstract":"Background Chronic conditions (CC) may increase the risk of herpes zoster (HZ) infection, leading to a greater healthcare burden in these individuals compared to those without CCs. It is therefore clinically important to quantify HZ disease burden in individuals with and without CCs, given the rapidly ageing population in the Republic of Korea (ROK). Methods This retrospective cohort study examines the trends in incidence rates (IRs) and incidence rate ratios (IRRs) in individuals with CCs aged ≥18 years using the National Health Insurance Service National Sample Cohort (NHIS-NSC) database from 2010–2019. These patients were stratified by age groups, sex, HZ complications, and CCs. The annual average number of HZ patients, IRs and IRRs were calculated for individuals with and without CCs. Results In total, 729,347 patients with HZ were eligible for the study. HZ IRs were highest in patients with diabetes, followed by chronic obstructive pulmonary disease, chronic kidney disease, asthma, and chronic liver disease, with HZ IRRs following a similar trend. Overall, HZ IRs generally increased with age, typically peaking at 60–64 or 65–69 years and were similar for females and males. HZ IRs were highest among patients without complications, followed by HZ with other, cutaneous, ocular, and neurologic complications across all CCs. For each of the CCs, HZ IRs were consistently higher than that of the non-CC population regardless of sex. Conclusions The findings of this study reiterate the importance of HZ prevention for healthy ageing, especially for CCs populations at increased risk of HZ in the ROK.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in mpox evaluation by clinical care site: practice patterns across an academic medical system during the 2022 epidemic 临床医疗机构对麻风病评估的差异:2022 年流行病期间学术医疗系统的实践模式
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-18 DOI: 10.1093/ofid/ofae512
William M Garneau, Joyce L Jones, Gabriella M Dashler, Nathan Kwon, Matthew M Hamill, Elizabeth A Gilliams, David S Rudolph, Jeanne C Keruly, Eili Y Klein, Nae-Yuh Wang, Bhakti Hansoti, Kelly A Gebo
Background Patients with suspected mpox presented to different venues for evaluation during the 2022 outbreak. We hypothesized that practice patterns may differ across venue of care. Methods We conducted an observational study of patients undergoing mpox testing between June 1, 2022 – December 15, 2022. We assessed concomitant STI testing, sexual history, and anogenital exam and a composite outcome of all three, stratified by site. Venue of care was defined as ED (emergency department or urgent care), ID (infectious disease clinic), or PCP (primary care or other outpatient clinic). Results Of 276 patients included, over half (62.7%) were evaluated in the ED. Sexual history, anogenital exam and STI testing were documented as performed at a higher rate in ID clinic compared to ED or PCP settings. STIs were diagnosed in 20.4% of patients diagnosed with mpox, and syphilis was the most common STI among patients diagnosed with mpox (17.5%). Patients evaluated in ID clinic had higher odds ratio of completing all three measures (aOR 3.6 [95% CI 1.4-9.3]) compared to PCP setting adjusted for age, gender and MSM status. Cisgender men who have sex with men, transgender males and transgender females had higher odds ratio of completing all three measures compared to cisgender females (aOR 4.0 [95% CI 1.9-8.4]) adjusted for age and venue of care. Conclusions Care varied across clinical sites. ID clinics performed a more thorough evaluation than other venues. Rates of STI coinfection were high. Syphilis was the most common STI. Efforts to standardize care are important to ensure optimal outcomes for patients.
背景 在 2022 年疫情爆发期间,疑似麻风病人在不同地点接受了评估。我们推测,不同医疗机构的诊疗模式可能有所不同。方法 我们对 2022 年 6 月 1 日至 2022 年 12 月 15 日期间接受水痘检测的患者进行了一项观察性研究。我们评估了同时进行的性传播感染检测、性生活史和肛门生殖器检查,以及三者的综合结果,并按地点进行了分层。就诊地点定义为 ED(急诊科或急诊室)、ID(传染病诊所)或 PCP(初级保健或其他门诊诊所)。结果 在纳入的 276 名患者中,一半以上(62.7%)是在急诊室接受评估的。根据记录,与急诊室或初级保健中心相比,ID 诊所的性史、肛门生殖器检查和 STI 检测率更高。20.4%的麻疹患者被诊断出患有性传播感染,梅毒是麻疹患者中最常见的性传播感染(17.5%)。经年龄、性别和 MSM 身份调整后,与初级保健医生相比,在 ID 诊所接受评估的患者完成所有三项措施的几率更高(aOR 3.6 [95% CI 1.4-9.3])。经年龄和医疗地点调整后,与同性女性相比,同性男性同性恋者、变性男性和变性女性完成所有三项测量的几率更高(aOR 4.0 [95% CI 1.9-8.4])。结论 不同临床机构的护理有所不同。ID 诊所的评估比其他场所更全面。性传播疾病合并感染率很高。梅毒是最常见的性传播疾病。为确保患者获得最佳治疗效果,必须努力实现护理标准化。
{"title":"Differences in mpox evaluation by clinical care site: practice patterns across an academic medical system during the 2022 epidemic","authors":"William M Garneau, Joyce L Jones, Gabriella M Dashler, Nathan Kwon, Matthew M Hamill, Elizabeth A Gilliams, David S Rudolph, Jeanne C Keruly, Eili Y Klein, Nae-Yuh Wang, Bhakti Hansoti, Kelly A Gebo","doi":"10.1093/ofid/ofae512","DOIUrl":"https://doi.org/10.1093/ofid/ofae512","url":null,"abstract":"Background Patients with suspected mpox presented to different venues for evaluation during the 2022 outbreak. We hypothesized that practice patterns may differ across venue of care. Methods We conducted an observational study of patients undergoing mpox testing between June 1, 2022 – December 15, 2022. We assessed concomitant STI testing, sexual history, and anogenital exam and a composite outcome of all three, stratified by site. Venue of care was defined as ED (emergency department or urgent care), ID (infectious disease clinic), or PCP (primary care or other outpatient clinic). Results Of 276 patients included, over half (62.7%) were evaluated in the ED. Sexual history, anogenital exam and STI testing were documented as performed at a higher rate in ID clinic compared to ED or PCP settings. STIs were diagnosed in 20.4% of patients diagnosed with mpox, and syphilis was the most common STI among patients diagnosed with mpox (17.5%). Patients evaluated in ID clinic had higher odds ratio of completing all three measures (aOR 3.6 [95% CI 1.4-9.3]) compared to PCP setting adjusted for age, gender and MSM status. Cisgender men who have sex with men, transgender males and transgender females had higher odds ratio of completing all three measures compared to cisgender females (aOR 4.0 [95% CI 1.9-8.4]) adjusted for age and venue of care. Conclusions Care varied across clinical sites. ID clinics performed a more thorough evaluation than other venues. Rates of STI coinfection were high. Syphilis was the most common STI. Efforts to standardize care are important to ensure optimal outcomes for patients.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Value of Medical Chart Reviews: A Methodological Approach to Supplement Mortality Data During Pandemic Outbreaks 病历审查的价值:大流行疫情爆发期间补充死亡率数据的方法学途径
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-18 DOI: 10.1093/ofid/ofae543
Elizabeth M Boos, Maxwell Holtmann, Jack DeHovitz, James M Tesoriero, Redd Driver, Charles Gonzalez
Administrative data may provide incomplete understanding of pandemic disease impact. Medical record review-based assessments of COVID-19-related causes of death (COD) among people living with diagnosed HIV in New York State identified more COVID-19-related COD compared to Vital Statistics and offer a deeper understanding of the pandemic’s impact on this population.
行政数据可能无法全面了解大流行病的影响。与生命统计数据相比,基于病历审查对纽约州已确诊艾滋病毒感染者中与 COVID-19 相关的死因(COD)进行的评估发现了更多与 COVID-19 相关的死因,从而更深入地了解了大流行病对这一人群的影响。
{"title":"The Value of Medical Chart Reviews: A Methodological Approach to Supplement Mortality Data During Pandemic Outbreaks","authors":"Elizabeth M Boos, Maxwell Holtmann, Jack DeHovitz, James M Tesoriero, Redd Driver, Charles Gonzalez","doi":"10.1093/ofid/ofae543","DOIUrl":"https://doi.org/10.1093/ofid/ofae543","url":null,"abstract":"Administrative data may provide incomplete understanding of pandemic disease impact. Medical record review-based assessments of COVID-19-related causes of death (COD) among people living with diagnosed HIV in New York State identified more COVID-19-related COD compared to Vital Statistics and offer a deeper understanding of the pandemic’s impact on this population.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimisation of the diagnosis of Central Nervous System infections in Vietnamese hospitals: Results from a retrospective multicentre study 越南医院中枢神经系统感染诊断的优化:一项回顾性多中心研究的结果
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-14 DOI: 10.1093/ofid/ofae531
Do Van Dong, Sébastien Boutin, Vu Viet Sang, Nguyen Dang Manh, Nghiem Xuan Hoan, Hoang Xuan Quang, Tran Thi Lien, Van Dinh Trang, Nguyen Trong The, Le Thi Kieu Linh, Kristina Schmauder, Viola Ueltzhöffer, Nourhane Hafza, Susanne Hauswaldt, Jan Rupp, Peter G Kremsner, Le Huu Song, Dennis Nurjadi, Silke Peter, Thirumalaisamy P Velavan
Introduction Central nervous system (CNS) infections pose significant health challenges, particularly in low- and middle-income countries (LMICs), due to high morbidity and mortality rates. Rapid and accurate diagnosis is essential for effective treatment to prevent adverse outcomes. Traditional culture-based diagnostics are often slow and lack specificity. This study evaluates the BioFire® FilmArray® Meningitis/Encephalitis (FAME) Panel against standard diagnostics in Vietnam to assess its clinical impact and suitability for local epidemiology. Methods We conducted a prospective study involving 330 patients with suspected CNS infections at four hospitals in northern Vietnam from July 2022 to April 2023. CSF samples were analysed using routine culture methods and FAME. We compared pathogen detection rates and assessed the potential clinical impact of FAME results on patient management. Results Of the 330 CSF specimens, 64 (19%) were positive by either conventional diagnostics (n=48) and/or FAME (n=33). The agreement between FAME and conventional diagnostics was 87%. Key pathogens Mycobacterium tuberculosis (n=7), Klebsiella pneumoniae (n=5), Streptococcus suis (n=5), Epstein-Barr virus (n=3), Acinetobacter baumannii (n=1), and Trichosporon asahii (n=1) were not detected by FAME. Classical meningitis parameters-clinical symptoms, altered glucose, protein, and pleocytosis- were good predictors of FAME positivity, indicating their utility in optimizing local diagnostic algorithms. Conclusion FAME complements traditional diagnostics by offering rapid and broad pathogen detection, crucial for timely and appropriate therapy. However, its effectiveness varies with local epidemiology, and it should not replace conventional methods entirely. Tailoring diagnostic panels to regional pathogen prevalence is recommended to enhance diagnostic accuracy and clinical outcomes in LMICs.
导言 中枢神经系统(CNS)感染因其发病率和死亡率高而对健康构成重大挑战,尤其是在中低收入国家(LMICs)。快速准确的诊断对于有效治疗以避免不良后果至关重要。传统的基于培养基的诊断通常速度较慢且缺乏特异性。本研究评估了 BioFire® FilmArray® 脑膜炎/脑炎(FAME)检测板与越南标准诊断方法的比较,以评估其临床影响和对当地流行病学的适用性。方法 我们开展了一项前瞻性研究,从 2022 年 7 月到 2023 年 4 月,越南北部四家医院共收治了 330 名疑似中枢神经系统感染患者。采用常规培养方法和 FAME 分析 CSF 样本。我们比较了病原体检出率,并评估了 FAME 结果对患者管理的潜在临床影响。结果 在 330 份 CSF 标本中,64 份(19%)在常规诊断(48 份)和/或 FAME(33 份)中呈阳性。FAME 与常规诊断的一致性为 87%。主要病原体结核分枝杆菌(7 例)、肺炎克雷伯菌(5 例)、猪链球菌(5 例)、Epstein-Barr 病毒(3 例)、鲍曼不动杆菌(1 例)和旭三代单胞菌(1 例)均未被 FAME 检测到。经典的脑膜炎参数--临床症状、葡萄糖、蛋白质和多形性细胞的改变--是预测 FAME 阳性的良好指标,表明它们在优化本地诊断算法中的作用。结论 FAME 是对传统诊断方法的补充,能快速、广泛地检测病原体,对及时、适当的治疗至关重要。然而,它的效果因当地流行病学而异,不应完全取代传统方法。建议根据地区病原体流行情况定制诊断面板,以提高诊断准确性,改善低收入和中等收入国家的临床效果。
{"title":"Optimisation of the diagnosis of Central Nervous System infections in Vietnamese hospitals: Results from a retrospective multicentre study","authors":"Do Van Dong, Sébastien Boutin, Vu Viet Sang, Nguyen Dang Manh, Nghiem Xuan Hoan, Hoang Xuan Quang, Tran Thi Lien, Van Dinh Trang, Nguyen Trong The, Le Thi Kieu Linh, Kristina Schmauder, Viola Ueltzhöffer, Nourhane Hafza, Susanne Hauswaldt, Jan Rupp, Peter G Kremsner, Le Huu Song, Dennis Nurjadi, Silke Peter, Thirumalaisamy P Velavan","doi":"10.1093/ofid/ofae531","DOIUrl":"https://doi.org/10.1093/ofid/ofae531","url":null,"abstract":"Introduction Central nervous system (CNS) infections pose significant health challenges, particularly in low- and middle-income countries (LMICs), due to high morbidity and mortality rates. Rapid and accurate diagnosis is essential for effective treatment to prevent adverse outcomes. Traditional culture-based diagnostics are often slow and lack specificity. This study evaluates the BioFire® FilmArray® Meningitis/Encephalitis (FAME) Panel against standard diagnostics in Vietnam to assess its clinical impact and suitability for local epidemiology. Methods We conducted a prospective study involving 330 patients with suspected CNS infections at four hospitals in northern Vietnam from July 2022 to April 2023. CSF samples were analysed using routine culture methods and FAME. We compared pathogen detection rates and assessed the potential clinical impact of FAME results on patient management. Results Of the 330 CSF specimens, 64 (19%) were positive by either conventional diagnostics (n=48) and/or FAME (n=33). The agreement between FAME and conventional diagnostics was 87%. Key pathogens Mycobacterium tuberculosis (n=7), Klebsiella pneumoniae (n=5), Streptococcus suis (n=5), Epstein-Barr virus (n=3), Acinetobacter baumannii (n=1), and Trichosporon asahii (n=1) were not detected by FAME. Classical meningitis parameters-clinical symptoms, altered glucose, protein, and pleocytosis- were good predictors of FAME positivity, indicating their utility in optimizing local diagnostic algorithms. Conclusion FAME complements traditional diagnostics by offering rapid and broad pathogen detection, crucial for timely and appropriate therapy. However, its effectiveness varies with local epidemiology, and it should not replace conventional methods entirely. Tailoring diagnostic panels to regional pathogen prevalence is recommended to enhance diagnostic accuracy and clinical outcomes in LMICs.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Turnaround Times for Antigen Testing in Hospitalized Patients with Histoplasmosis and Blastomycosis 对组织胞浆菌病和大疱菌病住院患者抗原检测周转时间的评估
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-14 DOI: 10.1093/ofid/ofae521
Liam M Dalton, Carol A Kauffman, Blair Richards, Marisa H Miceli
Review of histoplasmosis and blastomycosis antigen testing for 39 patients hospitalized with these diseases found that there were significantly longer turnaround times between the time of specimen collection and receipt of positive test results among those patients who had worse outcomes.
在对 39 名住院的组织胞浆菌病和囊霉菌病患者进行抗原检测后发现,在结果较差的患者中,从采集标本到收到阳性检测结果之间的周转时间明显较长。
{"title":"Evaluation of Turnaround Times for Antigen Testing in Hospitalized Patients with Histoplasmosis and Blastomycosis","authors":"Liam M Dalton, Carol A Kauffman, Blair Richards, Marisa H Miceli","doi":"10.1093/ofid/ofae521","DOIUrl":"https://doi.org/10.1093/ofid/ofae521","url":null,"abstract":"Review of histoplasmosis and blastomycosis antigen testing for 39 patients hospitalized with these diseases found that there were significantly longer turnaround times between the time of specimen collection and receipt of positive test results among those patients who had worse outcomes.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinant of 30-day Mortality of Pulmonary Legionellosis: Do Co-Infections Matter? 肺军团菌病 30 天死亡率的决定因素:合并感染重要吗?
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-13 DOI: 10.1093/ofid/ofae529
Takahiro Matsuo, Sebastian Wurster, Ying Jiang, Jeffrey Tarrand, Scott E Evans, Dimitrios P Kontoyiannis
We retrospectively reviewed 64 cancer patients with pulmonary legionellosis (Legionella pneumophila in 73%). Nearly all patients received Legionella-active antibiotics, yet 30-day mortality was 23%. Independent predictors of 30-day mortality were hyponatremia, bilateral lung involvement, and SOFA score ≥5. Lung co-infections were common (31%) but did not significantly increase mortality.
我们对 64 名患肺军团菌病的癌症患者(73% 患有嗜肺军团菌病)进行了回顾性研究。几乎所有患者都接受了军团菌活性抗生素治疗,但 30 天死亡率为 23%。低钠血症、双肺受累和 SOFA 评分≥5 分是预测 30 天死亡率的独立因素。肺部合并感染很常见(31%),但并不会显著增加死亡率。
{"title":"Determinant of 30-day Mortality of Pulmonary Legionellosis: Do Co-Infections Matter?","authors":"Takahiro Matsuo, Sebastian Wurster, Ying Jiang, Jeffrey Tarrand, Scott E Evans, Dimitrios P Kontoyiannis","doi":"10.1093/ofid/ofae529","DOIUrl":"https://doi.org/10.1093/ofid/ofae529","url":null,"abstract":"We retrospectively reviewed 64 cancer patients with pulmonary legionellosis (Legionella pneumophila in 73%). Nearly all patients received Legionella-active antibiotics, yet 30-day mortality was 23%. Independent predictors of 30-day mortality were hyponatremia, bilateral lung involvement, and SOFA score ≥5. Lung co-infections were common (31%) but did not significantly increase mortality.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142269167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infections Following Gender-affirming Vaginoplasty: A Single Center Experience 性别确认阴道成形术后的感染:单中心经验
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-11 DOI: 10.1093/ofid/ofae526
Radhika Sheth, Apoorva Bhaskara, Haley Brown, Cara D Varley, Amber Streifel, Marissa Maier, Monica K Sikka, Christopher Evans
We describe the epidemiology and incidence of infections following gender-affirming vaginoplasty. Urinary tract and surgical site infections were the most common infections with 17.5% and 5.5% incidence, respectively. We also identified a significant gap in Human Immunodeficiency Virus screening and prescription of pre-exposure prophylaxis.
我们描述了性别确认阴道成形术后感染的流行病学和发病率。尿路感染和手术部位感染是最常见的感染,发生率分别为 17.5% 和 5.5%。我们还发现,在人类免疫缺陷病毒筛查和接触前预防处方方面存在很大差距。
{"title":"Infections Following Gender-affirming Vaginoplasty: A Single Center Experience","authors":"Radhika Sheth, Apoorva Bhaskara, Haley Brown, Cara D Varley, Amber Streifel, Marissa Maier, Monica K Sikka, Christopher Evans","doi":"10.1093/ofid/ofae526","DOIUrl":"https://doi.org/10.1093/ofid/ofae526","url":null,"abstract":"We describe the epidemiology and incidence of infections following gender-affirming vaginoplasty. Urinary tract and surgical site infections were the most common infections with 17.5% and 5.5% incidence, respectively. We also identified a significant gap in Human Immunodeficiency Virus screening and prescription of pre-exposure prophylaxis.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142189221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effects of 23-valent pneumococcal polysaccharide vaccination against mortality: The VENUS Study 接种 23 价肺炎球菌多糖疫苗对降低死亡率的保护作用:VENUS 研究
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-11 DOI: 10.1093/ofid/ofae530
Fumiko Murata, Megumi Maeda, Haruhisa Fukuda
This retrospective matched cohort study investigated the protective effects of PPSV23 vaccination against pneumonia mortality and all-cause mortality in Japanese adults aged ≥65 years. We analyzed claims data, vaccination records, and death certificate records between October 2016 and December 2019 from 55,509 PPSV23 vaccinated individuals and 55,509 unvaccinated individuals. Cox proportional hazards analyses were performed to calculate the adjusted hazard ratios (HRs) of PPSV23 vaccination for mortality. The results showed that PPSV23 vaccination was significantly associated with a reduction in all-cause mortality (adjusted HR: 0.52, P<0.001), but not pneumonia mortality (adjusted HR: 0.70, P=0.374).
这项回顾性匹配队列研究调查了接种 PPSV23 疫苗对≥65 岁日本成年人肺炎死亡率和全因死亡率的保护作用。我们分析了 2016 年 10 月至 2019 年 12 月期间 55509 名接种过 PPSV23 疫苗的人和 55509 名未接种过疫苗的人的索赔数据、疫苗接种记录和死亡证明记录。通过 Cox 比例危险度分析,计算出接种 PPSV23 疫苗对死亡率的调整危险比 (HR)。结果显示,接种PPSV23疫苗与全因死亡率的降低显著相关(调整后的HR:0.52,P<0.001),但与肺炎死亡率无关(调整后的HR:0.70,P=0.374)。
{"title":"Protective effects of 23-valent pneumococcal polysaccharide vaccination against mortality: The VENUS Study","authors":"Fumiko Murata, Megumi Maeda, Haruhisa Fukuda","doi":"10.1093/ofid/ofae530","DOIUrl":"https://doi.org/10.1093/ofid/ofae530","url":null,"abstract":"This retrospective matched cohort study investigated the protective effects of PPSV23 vaccination against pneumonia mortality and all-cause mortality in Japanese adults aged ≥65 years. We analyzed claims data, vaccination records, and death certificate records between October 2016 and December 2019 from 55,509 PPSV23 vaccinated individuals and 55,509 unvaccinated individuals. Cox proportional hazards analyses were performed to calculate the adjusted hazard ratios (HRs) of PPSV23 vaccination for mortality. The results showed that PPSV23 vaccination was significantly associated with a reduction in all-cause mortality (adjusted HR: 0.52, P<0.001), but not pneumonia mortality (adjusted HR: 0.70, P=0.374).","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142189102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging Echinocandin with Azole antifungal Therapy On Prevention Of Invasive Candidiasis Post Lung Transplantation 衔接棘白菌素与阿唑类抗真菌疗法,预防肺移植后的侵袭性念珠菌病
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-11 DOI: 10.1093/ofid/ofae525
Taylor Pasley, Christopher Baladad, Kathryn DeSear, Solmaz Karimi, Eric Rubido, Guy El Helou, Maureen Converse
Background Invasive Candidiasis (IC) is a significant factor for lung transplant recipient (LTR) mortality, especially in the immediate postoperative phase. Receipt of antifungal prophylaxis has demonstrated lower all-cause mortality. Methods This was a single-center, retrospective cohort study of LTR between August 2017 and August 2020. Included patients were adult LTR with positive Candida cultures pre-operatively (donor or recipient) or within 6 weeks postoperatively. Patients were divided into 2 cohorts—bridged and unbridged. The bridged cohort received micafungin in the postoperative period until therapeutic azole concentrations were achieved or up to 2 weeks, whichever was sooner. The primary outcome was a composite of proven or probable invasive candidiasis. Results A total of 117 patients were included in the study, with 68 in the unbridged cohort and 49 in the bridged cohort. There was more IC in the bridged cohort compared to the unbridged cohort (p = 0.011). Conclusion In combination with an azole antifungal, micafungin did not prevent IC in postoperative LTR with cultures positive for Candida species in this cohort. Larger prospective studies are needed to determine the ideal combination and duration of antifungal prophylaxis.
背景侵袭性念珠菌病(IC)是肺移植受者(LTR)死亡率的一个重要因素,尤其是在术后初期。接受抗真菌预防治疗可降低全因死亡率。方法 这是一项针对 2017 年 8 月至 2020 年 8 月期间 LTR 的单中心回顾性队列研究。纳入的患者为术前(供体或受体)或术后 6 周内念珠菌培养阳性的成人 LTR 患者。患者分为桥接和未桥接两组。桥接队列在术后接受米卡芬净治疗,直到达到唑类药物的治疗浓度或最长两周,以时间在前者为准。主要结果是经证实或可能的侵袭性念珠菌病的复合结果。结果 共有117名患者参与了研究,其中未桥接队列68人,桥接队列49人。与未桥接队列相比,桥接队列中的 IC 更多(p = 0.011)。结论 在该队列中,米卡芬净与唑类抗真菌药物联用,并不能预防白色念珠菌培养阳性的 LTR 术后 IC。需要进行更大规模的前瞻性研究,以确定理想的抗真菌预防组合和持续时间。
{"title":"Bridging Echinocandin with Azole antifungal Therapy On Prevention Of Invasive Candidiasis Post Lung Transplantation","authors":"Taylor Pasley, Christopher Baladad, Kathryn DeSear, Solmaz Karimi, Eric Rubido, Guy El Helou, Maureen Converse","doi":"10.1093/ofid/ofae525","DOIUrl":"https://doi.org/10.1093/ofid/ofae525","url":null,"abstract":"Background Invasive Candidiasis (IC) is a significant factor for lung transplant recipient (LTR) mortality, especially in the immediate postoperative phase. Receipt of antifungal prophylaxis has demonstrated lower all-cause mortality. Methods This was a single-center, retrospective cohort study of LTR between August 2017 and August 2020. Included patients were adult LTR with positive Candida cultures pre-operatively (donor or recipient) or within 6 weeks postoperatively. Patients were divided into 2 cohorts—bridged and unbridged. The bridged cohort received micafungin in the postoperative period until therapeutic azole concentrations were achieved or up to 2 weeks, whichever was sooner. The primary outcome was a composite of proven or probable invasive candidiasis. Results A total of 117 patients were included in the study, with 68 in the unbridged cohort and 49 in the bridged cohort. There was more IC in the bridged cohort compared to the unbridged cohort (p = 0.011). Conclusion In combination with an azole antifungal, micafungin did not prevent IC in postoperative LTR with cultures positive for Candida species in this cohort. Larger prospective studies are needed to determine the ideal combination and duration of antifungal prophylaxis.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142189101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Antibiotics Misuse and Cost Analysis among Hospitalized Dengue Virus Infected Adults: Insights from a Retrospective Cohort Study 评估成人登革热病毒感染者住院期间的抗生素滥用和成本分析:回顾性队列研究的启示
IF 4.2 4区 医学 Q2 IMMUNOLOGY Pub Date : 2024-09-10 DOI: 10.1093/ofid/ofae520
Thundon Ngamprasertchai, Ashley Siribhadra, Chayanis Kositamongkol, Pittaya Piroonamornpun, Piyanan Pakdeewut, Viravarn Luvira, Saranath Lawpoolsri, Pinyo Rattanaumpawan
Background Dengue is a prevalent cause of acute febrile illness, predominantly in Asia, where it necessitates supportive care without the need for antibiotics. This study aims to evaluate antibiotics usage and analyze the hospitalization costs among adults infected with the dengue virus. Methods This retrospective cohort study was conducted at the Hospital for Tropical Diseases, Thailand, in 2022. Two independent reviewers assessed all adult cases with confirmed dengue from 2016 to 2021. Determinants of inappropriateness were analyzed using Poisson regression. Results The study included 249 participants with over half presenting with severe dengue or dengue with warning signs upon admission. The cumulative incidence of antibiotics use was 9.3% (95% confidence interval [CI]: 8.23–10.47), predominantly involving empirical treatment strategies. Ceftriaxone and doxycycline were the most frequently prescribed antibiotics. Notably, patients who received empirical antibiotics showed no definite or presumed bacterial infections. Among those who received definite strategies, inappropriate durations, including both short treatments and the overuse of broad-spectrum antibiotics, were observed. A private ward admission was identified as a significant predictor of inappropriate use, with an incidence rate ratio of 4.15 (95% CI: 1.16–14.82) compared to ICU admission. Direct medical costs did not differ significantly between appropriate and inappropriate uses. Conclusions The incidence of antibiotic use among dengue cases was moderate; however, inappropriate use by indications were mainly observed. Antimicrobial Stewardship (AMS) strategies should be encouraged, particularly in dengue with warning signs, admitted to general or private ward. Direct medical costs between appropriate and inappropriate uses were comparable.
背景登革热是急性发热性疾病的一种常见病因,主要发生在亚洲,患者只需接受支持性治疗,无需使用抗生素。本研究旨在评估抗生素的使用情况,并分析感染登革热病毒的成人的住院费用。方法 这项回顾性队列研究于 2022 年在泰国热带病医院进行。两名独立审查员对 2016 年至 2021 年期间所有确诊登革热的成人病例进行了评估。使用泊松回归分析了不适当性的决定因素。结果 研究纳入了 249 名参与者,其中一半以上在入院时出现严重登革热或登革热警示症状。抗生素使用的累计发生率为 9.3%(95% 置信区间 [CI]:8.23-10.47),主要涉及经验性治疗策略。头孢曲松和强力霉素是最常用的抗生素。值得注意的是,接受经验性抗生素治疗的患者没有明确或推测的细菌感染。在接受确诊治疗的患者中,发现了不恰当的用药时间,包括短期治疗和过度使用广谱抗生素。与入住重症监护室相比,入住私人病房是不适当使用抗生素的一个重要预测因素,其发生率比为 4.15(95% CI:1.16-14.82)。直接医疗成本在合理使用和不当使用之间没有明显差异。结论 登革热病例中抗生素使用率适中,但主要存在适应症使用不当的情况。应鼓励采取抗菌药物管理(AMS)策略,尤其是对有预警征兆、住在普通病房或私人病房的登革热患者。适当使用和不适当使用的直接医疗成本相当。
{"title":"Evaluating Antibiotics Misuse and Cost Analysis among Hospitalized Dengue Virus Infected Adults: Insights from a Retrospective Cohort Study","authors":"Thundon Ngamprasertchai, Ashley Siribhadra, Chayanis Kositamongkol, Pittaya Piroonamornpun, Piyanan Pakdeewut, Viravarn Luvira, Saranath Lawpoolsri, Pinyo Rattanaumpawan","doi":"10.1093/ofid/ofae520","DOIUrl":"https://doi.org/10.1093/ofid/ofae520","url":null,"abstract":"Background Dengue is a prevalent cause of acute febrile illness, predominantly in Asia, where it necessitates supportive care without the need for antibiotics. This study aims to evaluate antibiotics usage and analyze the hospitalization costs among adults infected with the dengue virus. Methods This retrospective cohort study was conducted at the Hospital for Tropical Diseases, Thailand, in 2022. Two independent reviewers assessed all adult cases with confirmed dengue from 2016 to 2021. Determinants of inappropriateness were analyzed using Poisson regression. Results The study included 249 participants with over half presenting with severe dengue or dengue with warning signs upon admission. The cumulative incidence of antibiotics use was 9.3% (95% confidence interval [CI]: 8.23–10.47), predominantly involving empirical treatment strategies. Ceftriaxone and doxycycline were the most frequently prescribed antibiotics. Notably, patients who received empirical antibiotics showed no definite or presumed bacterial infections. Among those who received definite strategies, inappropriate durations, including both short treatments and the overuse of broad-spectrum antibiotics, were observed. A private ward admission was identified as a significant predictor of inappropriate use, with an incidence rate ratio of 4.15 (95% CI: 1.16–14.82) compared to ICU admission. Direct medical costs did not differ significantly between appropriate and inappropriate uses. Conclusions The incidence of antibiotic use among dengue cases was moderate; however, inappropriate use by indications were mainly observed. Antimicrobial Stewardship (AMS) strategies should be encouraged, particularly in dengue with warning signs, admitted to general or private ward. Direct medical costs between appropriate and inappropriate uses were comparable.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142189222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Open Forum Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1